Markers of inflammation and their clinical significance
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 6 (2), 21-29
- https://doi.org/10.1016/j.atherosclerosissup.2005.02.005
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover studyAtherosclerosis, 2004
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk ScoreCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular CellsCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin THeart, 2001
- Cellular Source(s) of Platelet-Activating-Factor Acetylhydrolase Activity in PlasmaBiochemical and Biophysical Research Communications, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998